Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cell Chemical Biology|July 19, 2024
Therapeutic potential of inhibiting the PI3Kγ complex for leukemiaHanna Karvonen, Neil Vasan
Methods in Enzymology|May 7, 2022
Cellular thermal shift assay (CETSA) for determining the drug binding affinity using Ba/F3 clones stably expressing receptor pseudokinasesHanna Karvonen, Juuli Raivola, Daniela Ungureanu
Biochemical Society Transactions|April 15, 2017
Targeting ROR1 identifies new treatment strategies in hematological cancersHanna Karvonen, Wilhelmiina Niininen, Astrid Murumägi, et al.
Cells|August 7, 2019
Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 PathwaysHanna Karvonen, Harlan Barker, Laura Kaleva, et al.
European Journal of Haematology|July 11, 2018
Targeting Wnt signaling pseudokinases in hematological cancersHanna Karvonen, Robert Perttilä, Wilhelmiina Niininen, et al.
FEBS Letters|January 3, 2018
Interaction between ROR1 and MuSK activation complex in myogenic cellsHanna Karvonen, Katja Summala, Wilhelmiina Niininen, et al.
Cancers|August 7, 2021
Evaluating Targeted Therapies in Ovarian Cancer Metabolism: Novel Role for PCSK9 and Second Generation mTOR InhibitorsDafne Jacome Sanz, Juuli Raivola, Hanna Karvonen, et al.
Cellular and Molecular Life Sciences : CMLS|May 3, 2022
New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactomeJuuli Raivola, Alice Dini, Kari Salokas, et al.
Oncogene|January 12, 2019
Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targetingHanna Karvonen, Robert Perttilä, Wilhelmiina Niininen, et al.
Blood Advances|January 4, 2018
Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphomaHanna Karvonen, David Chiron, Wilhelmiina Niininen, et al.
Pageof 2